![]() Oragenics Oragenics provides a novel antibiotics against infectious disease and develops effective treatments for oral mucositis. | NexImmune NexImmune is a biopharmaceutical company developing immunotherapy products based on the Artificial Immune Modulation nanotechnology platform. | ||
Founding Date | Founding Date 2009 | Founding Date 1996 | Founding Date 2011 |
Type | Type Public | Type Public | Type Public |
Tags | |||
Locations | Locations West Lake Hills, US HQ Austin, US | Locations Tampa, US HQ | Locations Gaithersburg, US HQ |
Employees | Employees 2865% increase | Employees 717% increase | Employees 5032% decrease |
Valuation ($) | Valuation ($) 6.3 m | Valuation ($) 3.3 m | Valuation ($) 372.4 k |
Financial | |||
Net income | Net income ($21.1m) (FY, 2024) | Net income ($10.6m) (FY, 2024) | Net income ($32.3m) (FY, 2023) |
Funding | |||
Total funding raised | Total funding raised N/A | Total funding raised $ 9.9m | Total funding raised $ 33.8m |
Oragenics provides a novel antibiotics against infectious disease and develops effective treatments for oral mucositis.
View companyNexImmune is a biopharmaceutical company developing immunotherapy products based on the Artificial Immune Modulation nanotechnology platform.
View company